//
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk
Patient-tailored antithrombotic therapy following percutaneous coronary intervention
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk
A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)
Dual antiplatelet therapy: how, how long, and in which patients?
P2Y12 Inhibitor Monotherapy with Clopidogrel Versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention